Economy/Home · Economy

HLB Pharmaceutical's Q3 Operating Profit Surges 2,383.7%... Revenue Reaches 62.5 Billion Won

HLB Pharmaceutical recorded consolidated operating profit of 850 million won in the third quarter of 2026, a 2,383.7% surge compared to the same period last year. Third-quarter revenue came to 62.5 billion won, up 3.1% from a year earlier. The company disclosed the results in a regulatory filing on

Wooil Shim
Staff Reporter
4 min read
HLB Pharmaceutical's Q3 Operating Profit Surges 2,383.7%... Revenue Reaches 62.5 Billion Won
CBC News

HLB Pharmaceutical recorded consolidated operating profit of 850 million won in the third quarter of 2026, a 2,383.7% surge compared to the same period last year. Third-quarter revenue came to 62.5 billion won, up 3.1% from a year earlier. The company disclosed the results in a regulatory filing on the 13th. Operating profit in the same period last year was in the 3.4 million won range.

Factors Behind Q3 Performance

HLB Pharmaceutical cited ▲the establishment of new products ▲improvements in cost of goods sold structure ▲expansion of sales channels and ▲reduced sales agency commissions as growth factors behind the results.

Cumulative Revenue of 190.4 Billion Won... Operating Profit Up 707.5%

Both revenue and operating profit increased in cumulative results through the third quarter of this year. Cumulative revenue rose 34.0% year-on-year to 190.4 billion won, while cumulative operating profit jumped 707.5% to 1.85 billion won.

Performance by Segment and Subsidiary

  • Ethical drugs (ETC): Cumulative revenue of 104.6 billion won, up 11.5% year-on-year
  • Contract manufacturing (CMO): Cumulative revenue of 5.26 billion won, up 9.0% year-on-year
  • Consumer healthcare: Cumulative revenue of 16.4 billion won, up 40.3% year-on-year
  • Pharmaceutical distribution subsidiary Shinhwa Advance: Cumulative revenue of 65.987 billion won, up 18.0% year-on-year

In summary, HLB Pharmaceutical posted consolidated operating profit of 850 million won and revenue of 62.5 billion won on a third-quarter basis, and achieved operating profit of 1.85 billion won and revenue of 190.4 billion won on a cumulative basis through the third quarter.

[Some AI assistance was used in producing this article. This article does not recommend buying or selling any specific stock, and investment decisions and responsibilities rest with the investor.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.